pharma-话题@MedSci

#pharma#

608篇内容 | 2509人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1908550, encodeId=475419085504d, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Eur Rev Med Pharmacol Sci:妊娠可影响牙周病的发展, objectType=article, longId=175404, objectId=17361e54044b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17361e54044b, replyNumber=0, likeNumber=72, createdTime=2019-07-30, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17361e54044b, moduleTitle=Eur Rev Med Pharmacol Sci:妊娠可影响牙周病的发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17361e54044b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908545, encodeId=572919085452d, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Be The Match BioTherapies和Kiadis Pharma宣布战略合作以加速造血干细胞移植疗法, objectType=article, longId=166721, objectId=b315166e2142, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b315166e2142, replyNumber=0, likeNumber=55, createdTime=2019-09-13, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b315166e2142, moduleTitle=Be The Match BioTherapies和Kiadis Pharma宣布战略合作以加速造血干细胞移植疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b315166e2142)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908554, encodeId=f7631908554b3, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Immunopharmacol Immunotoxicol：Sulglycotide通过阻断NF-κB信号传导途径改善巨噬细胞中的炎症, objectType=article, longId=176305, objectId=2c551e63051c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c551e63051c, replyNumber=0, likeNumber=70, createdTime=2020-01-30, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c551e63051c, moduleTitle=Immunopharmacol Immunotoxicol：Sulglycotide通过阻断NF-κB信号传导途径改善巨噬细胞中的炎症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c551e63051c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908556, encodeId=a03f1908556b1, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Biomed Pharmacother：cinaciguat联合胰岛素治疗可有效治疗糖尿病造成的种植失败, objectType=article, longId=177158, objectId=67421e715857, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67421e715857, replyNumber=0, likeNumber=69, createdTime=2020-03-31, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67421e715857, moduleTitle=Biomed Pharmacother：cinaciguat联合胰岛素治疗可有效治疗糖尿病造成的种植失败, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=67421e715857)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908531, encodeId=8ef719085313c, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Espero BioPharma宣布Tecarfarin治疗终末期肾病和心房颤动患者获得FDA孤儿药物指定, objectType=article, longId=162178, objectId=41161621e864, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41161621e864, replyNumber=0, likeNumber=51, createdTime=2019-06-11, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41161621e864, moduleTitle=Espero BioPharma宣布Tecarfarin治疗终末期肾病和心房颤动患者获得FDA孤儿药物指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41161621e864)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908528, encodeId=642919085281c, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Mitochon Pharmaceuticals的MP-101治疗亨廷顿舞蹈病获得FDA孤儿药物指定, objectType=article, longId=161780, objectId=3be5161e8072, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3be5161e8072, replyNumber=0, likeNumber=58, createdTime=2019-03-08, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3be5161e8072, moduleTitle=Mitochon Pharmaceuticals的MP-101治疗亨廷顿舞蹈病获得FDA孤儿药物指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3be5161e8072)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908488, encodeId=15bc1908488f0, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Eur Rev Med Pharmacol Sci：血清炎症标志物与糖尿病视网膜病变的关联-文献综述, objectType=article, longId=154908, objectId=6a41154908a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a41154908a7, replyNumber=0, likeNumber=105, createdTime=2019-07-28, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a41154908a7, moduleTitle=Eur Rev Med Pharmacol Sci：血清炎症标志物与糖尿病视网膜病变的关联-文献综述, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a41154908a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908489, encodeId=49c41908489f7, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Ann Pharmacother：COPD急性加重：全身性糖皮质激素要联合ICS吗？, objectType=article, longId=155422, objectId=33b21554225d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33b21554225d, replyNumber=0, likeNumber=71, createdTime=2019-09-02, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33b21554225d, moduleTitle=Ann Pharmacother：COPD急性加重：全身性糖皮质激素要联合ICS吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33b21554225d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908526, encodeId=281019085260d, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Hansa Biopharma宣布欧洲药品管理局接受IDEFIRIX（imlifidase）用于高度敏感的肾移植患者的营销授权申请, objectType=article, longId=161543, objectId=416d16154305, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=416d16154305, replyNumber=0, likeNumber=49, createdTime=2020-01-13, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=416d16154305, moduleTitle=Hansa Biopharma宣布欧洲药品管理局接受IDEFIRIX（imlifidase）用于高度敏感的肾移植患者的营销授权申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=416d16154305)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908523, encodeId=ceb21908523d3, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Helsinn和MEI Pharma公布Pracinostat联合阿扎胞苷治疗AML的II期临床数据, objectType=article, longId=160407, objectId=b51a16040ede, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b51a16040ede, replyNumber=0, likeNumber=76, createdTime=2019-02-27, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b51a16040ede, moduleTitle=Helsinn和MEI Pharma公布Pracinostat联合阿扎胞苷治疗AML的II期临床数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b51a16040ede)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908506, encodeId=71bf1908506d4, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Ann Pharmacother：心脏手术患者围手术期镇静：基于右美托咪定vs基于丙泊酚方案, objectType=article, longId=157467, objectId=12e215e467ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12e215e467ff, replyNumber=0, likeNumber=62, createdTime=2019-10-01, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12e215e467ff, moduleTitle=Ann Pharmacother：心脏手术患者围手术期镇静：基于右美托咪定vs基于丙泊酚方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=12e215e467ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908521, encodeId=d773190852117, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Neuropsychopharmacology：女性荷尔蒙在成瘾中的作用：复发率更高, objectType=article, longId=159793, objectId=e610159e932e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e610159e932e, replyNumber=0, likeNumber=63, createdTime=2019-02-23, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e610159e932e, moduleTitle=Neuropsychopharmacology：女性荷尔蒙在成瘾中的作用：复发率更高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e610159e932e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908512, encodeId=7bd019085129b, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Destiny Pharma将获得160万英镑资助用以研究抗菌药物耐药性, objectType=article, longId=159135, objectId=75a1159135b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75a1159135b8, replyNumber=0, likeNumber=54, createdTime=2019-05-09, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75a1159135b8, moduleTitle=Destiny Pharma将获得160万英镑资助用以研究抗菌药物耐药性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75a1159135b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908484, encodeId=091a1908484d7, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Pharmacotherapy：痴呆的发生和苯二氮䓬类药物使用之间到底有无相关性, objectType=article, longId=154206, objectId=08221542067a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=08221542067a, replyNumber=0, likeNumber=56, createdTime=2018-12-27, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=08221542067a, moduleTitle=Pharmacotherapy：痴呆的发生和苯二氮䓬类药物使用之间到底有无相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=08221542067a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908525, encodeId=e43019085259d, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Bexion Pharmaceuticals宣布开展I期试验的第3部分以评价BXQ-350治疗癌症的可行性, objectType=article, longId=161122, objectId=d5d316112204, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5d316112204, replyNumber=0, likeNumber=72, createdTime=2019-11-05, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5d316112204, moduleTitle=Bexion Pharmaceuticals宣布开展I期试验的第3部分以评价BXQ-350治疗癌症的可行性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5d316112204)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908514, encodeId=f0a91908514de, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Theravance Biopharma宣布Ampreloxetine III期研究治疗症状性神经源性直立性低血压患者入组, objectType=article, longId=159219, objectId=850a159219d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=850a159219d1, replyNumber=0, likeNumber=61, createdTime=2019-11-17, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=850a159219d1, moduleTitle=Theravance Biopharma宣布Ampreloxetine III期研究治疗症状性神经源性直立性低血压患者入组, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=850a159219d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908504, encodeId=9b161908504bb, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Eur Rev Med Pharmacol Sci：miR-487b能够通过对IL-33/ST2信号途径的抑制减轻过敏性鼻炎, objectType=article, longId=157192, objectId=78f115e19289, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78f115e19289, replyNumber=0, likeNumber=78, createdTime=2019-10-17, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78f115e19289, moduleTitle=Eur Rev Med Pharmacol Sci：miR-487b能够通过对IL-33/ST2信号途径的抑制减轻过敏性鼻炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78f115e19289)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908515, encodeId=c9371908515fc, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Biomed Pharmacother：地塞米松通过ROS-PI3K/AKT/GSK3β信号通路诱导成骨细胞凋亡, objectType=article, longId=159495, objectId=60281594950a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60281594950a, replyNumber=0, likeNumber=58, createdTime=2019-12-31, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60281594950a, moduleTitle=Biomed Pharmacother：地塞米松通过ROS-PI3K/AKT/GSK3β信号通路诱导成骨细胞凋亡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60281594950a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908542, encodeId=d522190854282, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Biomed Pharmacother：含有氧化石墨烯的可注射热敏水凝胶有效促进成骨, objectType=article, longId=165274, objectId=29741652e48b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29741652e48b, replyNumber=0, likeNumber=57, createdTime=2019-11-21, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29741652e48b, moduleTitle=Biomed Pharmacother：含有氧化石墨烯的可注射热敏水凝胶有效促进成骨, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29741652e48b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908507, encodeId=7bb1190850e57, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Ann Pharmacother：产碳青霉烯酶肺炎克雷伯菌感染患者：双碳青霉烯联合疗法是否安全有效？, objectType=article, longId=157468, objectId=098a15e468e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=098a15e468e6, replyNumber=0, likeNumber=49, createdTime=2019-08-09, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=098a15e468e6, moduleTitle=Ann Pharmacother：产碳青霉烯酶肺炎克雷伯菌感染患者：双碳青霉烯联合疗法是否安全有效？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=098a15e468e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

pharma

2020-05-29

chentianping (审核中...)

前往app查看评论内容

#pharma#

Eur Rev Med Pharmacol Sci:妊娠可影响牙周病的发展

2019-07-30

chentianping (审核中...)

前往app查看评论内容

#pharma#

Be The Match BioTherapies和Kiadis Pharma宣布战略合作以加速造血干细胞移植疗法

2019-09-13

chentianping (审核中...)

前往app查看评论内容

#pharma#

Immunopharmacol Immunotoxicol：Sulglycotide通过阻断NF-κB信号传导途径改善巨噬细胞中的炎症

2020-01-30

chentianping (审核中...)

前往app查看评论内容

#pharma#

Biomed Pharmacother：cinaciguat联合胰岛素治疗可有效治疗糖尿病造成的种植失败

2020-03-31

chentianping (审核中...)

前往app查看评论内容

#pharma#

Espero BioPharma宣布Tecarfarin治疗终末期肾病和心房颤动患者获得FDA孤儿药物指定

2019-06-11

chentianping (审核中...)

前往app查看评论内容

#pharma#

Mitochon Pharmaceuticals的MP-101治疗亨廷顿舞蹈病获得FDA孤儿药物指定

2019-03-08

chentianping (审核中...)

前往app查看评论内容

#pharma#

Eur Rev Med Pharmacol Sci：血清炎症标志物与糖尿病视网膜病变的关联-文献综述

2019-07-28

chentianping (审核中...)

前往app查看评论内容

#pharma#

Ann Pharmacother：COPD急性加重：全身性糖皮质激素要联合ICS吗？

2019-09-02

chentianping (审核中...)

前往app查看评论内容

#pharma#

Hansa Biopharma宣布欧洲药品管理局接受IDEFIRIX（imlifidase）用于高度敏感的肾移植患者的营销授权申请

2020-01-13

chentianping (审核中...)

前往app查看评论内容

#pharma#

Helsinn和MEI Pharma公布Pracinostat联合阿扎胞苷治疗AML的II期临床数据

2019-02-27

chentianping (审核中...)

前往app查看评论内容

#pharma#

Ann Pharmacother：心脏手术患者围手术期镇静：基于右美托咪定vs基于丙泊酚方案

2019-10-01

chentianping (审核中...)

前往app查看评论内容

#pharma#

Neuropsychopharmacology：女性荷尔蒙在成瘾中的作用：复发率更高

2019-02-23

chentianping (审核中...)

前往app查看评论内容

#pharma#

Destiny Pharma将获得160万英镑资助用以研究抗菌药物耐药性

2019-05-09

chentianping (审核中...)

前往app查看评论内容

#pharma#

Pharmacotherapy：痴呆的发生和苯二氮䓬类药物使用之间到底有无相关性

2018-12-27

chentianping (审核中...)

前往app查看评论内容

#pharma#

Bexion Pharmaceuticals宣布开展I期试验的第3部分以评价BXQ-350治疗癌症的可行性

2019-11-05

chentianping (审核中...)

前往app查看评论内容

#pharma#

Theravance Biopharma宣布Ampreloxetine III期研究治疗症状性神经源性直立性低血压患者入组

2019-11-17

chentianping (审核中...)

前往app查看评论内容

#pharma#

Eur Rev Med Pharmacol Sci：miR-487b能够通过对IL-33/ST2信号途径的抑制减轻过敏性鼻炎

2019-10-17

chentianping (审核中...)

前往app查看评论内容

#pharma#

Biomed Pharmacother：地塞米松通过ROS-PI3K/AKT/GSK3β信号通路诱导成骨细胞凋亡

2019-12-31

chentianping (审核中...)

前往app查看评论内容

#pharma#

Biomed Pharmacother：含有氧化石墨烯的可注射热敏水凝胶有效促进成骨

2019-11-21

chentianping (审核中...)

前往app查看评论内容

#pharma#

Ann Pharmacother：产碳青霉烯酶肺炎克雷伯菌感染患者：双碳青霉烯联合疗法是否安全有效？

2019-08-09

科室
- - 订阅+
  - 更多科室
工具
服务